Restoring Nerve Function

Solaxa is a clinical-ready biopharmaceutical company developing treatments for
rare neurodegenerative disease and nerve injury.

 

We are pursuing both novel and reformulated drugs to
restore nerve function by targeting ion channels.

Our Company: By The Numbers

3

Investigator-initiated IND trials open

13

5 issued and 8 pending US, EU, Canada patents exclusively licensed

138

Cerebellar ataxia patients studied with drug

$8M+

Non-dilutive NIH & DoD grants to co-founders

20+

Peer-reviewed publications by co-founders

7

Different cerebellar ataxias have shown treatment response with drug

Scroll to Top